IP Verse

Pharmaceutical Composition - EP3515451

The patent EP3515451 was granted to Mexichem Fluor DE CV on Oct 4, 2023. The application was originally filed on Sep 18, 2017 under application number EP17777636A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3515451

MEXICHEM FLUOR DE CV
Application Number
EP17777636A
Filing Date
Sep 18, 2017
Status
Patent Maintained As Amended
Sep 1, 2023
Grant Date
Oct 4, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BECK GREENERAug 4, 2021BECK GREENERWITHDRAWN

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2007121913
INTERNATIONAL-SEARCH-REPORTWO2012156711
INTERNATIONAL-SEARCH-REPORTWO2017093758
OPPOSITIONWO2007121913
OPPOSITIONWO2012156711
OPPOSITIONWO2014170689
OPPOSITIONWO2017093758
OPPOSITIONWO9916422

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "AEROSOL DRUG DELIVERY", Gad Shayne Cox, Pharmaceutical manufacturing handbook Production and Processes, Hoboken, N.J, Wiley-Interscience, (20080101), pages 690 - 700-
OPPOSITION- "AEROSOL DRUG DELIVERY", Gad Shayne Cox, Pharmaceutical manufacturing handbook Production and Processes, Hoboken, N.J, Wiley-Interscience, (20080101), pages 690 - 700, XP055921018-
OPPOSITION- Anonymous, "Fostair 100/6 micrograms per actuation pressurised inhalation solution Summary of Product Characteristics Updated 03-Mar-2020 | Chiesi Limited", medicines.org, (20200303), pages 1 - 13, medicines.org, URL: https://www.medicines.org.uk/emc/product/6318/smpc/print, (20220513), XP055920996-
OPPOSITION- D. Purohit, A. Trehan And V. Arora, "Development of Room Temperature Stable Formulation of Formoterol Fumarate/Beclomethasone HFA pMDI", Indian Journal of Pharmaceutical Sciences, (20091101), vol. 71, no. 6, pages 713 - 715-
OPPOSITION- D. Purohit, A. Trehan And V. Arora, "Development of Room Temperature Stable Formulation of Formoterol Fumarate/Beclomethasone HFA pMDI", Indian Journal of Pharmaceutical Sciences, (20091101), vol. 71, no. 6, pages 713 - 715, XP055921001-
OPPOSITION- Myrdal Paul B., Sheth Poonam, Stein Stephen W., "Advances in Metered Dose Inhaler Technology: Formulation Development", AAPS PharmSciTech, (20140401), vol. 15, no. 2, doi:10.1208/s12249-013-0063-x, pages 434 - 455-
OPPOSITION- Paul M. Young, Daniela Traini, "Chapter 1 - Advances in Pulmonary Therapy ", Paul M. Young, Daniela Traini, Robert O Williams III, Taft David R, Mcconville Jason T, Advanced Drug Formulation Design to Optimize Therapeutic Outcomes, CRC PRess, (20080101), pages 1 - 36-
OPPOSITION- Paul M. Young, Daniela Traini, "Chapter 1 - Advances in Pulmonary Therapy ", Paul M. Young, Daniela Traini, Robert O Williams III, Taft David R, Mcconville Jason T, Advanced Drug Formulation Design to Optimize Therapeutic Outcomes, CRC PRess, (20080101), pages 1 - 36, XP055921021-
OPPOSITION- Sandy J.M. Munro, Alan L. Cripps, "Metered Dose Inhalers", Sandy J.M. Munro, Alan L. Cripps, JAMES SWARBRICK, ENCYCLOPEDIA OF PHARMACEUTICAL TECHNOLOGY THIRD EDITION, INFORMA HEALTHCARE USA, INC.,, (20070101), pages 2269 - 2284-
OPPOSITION- Sandy J.M. Munro, Alan L. Cripps, "Metered Dose Inhalers", Sandy J.M. Munro, Alan L. Cripps, JAMES SWARBRICK, ENCYCLOPEDIA OF PHARMACEUTICAL TECHNOLOGY THIRD EDITION, INFORMA HEALTHCARE USA, INC.,, (20070101), pages 2269 - 2284, XP055777448-
OPPOSITION- Myrdal Paul B., Sheth Poonam, Stein Stephen W., "Advances in Metered Dose Inhaler Technology: Formulation Development", AAPS PharmSciTech, (20140401), vol. 15, no. 2, doi:10.1208/s12249-013-0063-x, pages 434 - 455, XP055795960

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents